Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that…



Leave a Reply

Your email address will not be published. Required fields are marked *